

MCQOPTIONS
Saved Bookmarks
1. |
In December 2020, which company has partnered with Russia’s Gamaleya Research Institute, (RDIF) and R-Pharm to assess the safety and immunogenicity of a combination of their respective adenovirus-vector vaccines AZD1222 and Sputnik V? |
A. | bharat biotech |
B. | AstraZeneca |
C. | Biocon |
D. | Syngene International Limited |
E. | Cadila Healthcare |
Answer» C. Biocon | |